Annual report pursuant to Section 13 and 15(d)

Concentrations

v3.20.1
Concentrations
12 Months Ended
Dec. 31, 2019
Risks And Uncertainties [Abstract]  
Concentrations

NOTE 10 — CONCENTRATIONS

Revenue from the Company’s products for the years ended December 31, 2019, 2018 and 2017 are as follows:

 

 

Years Ended December 31,

 

 

 

2019

 

 

 

2018

 

 

 

2017

 

 

Laser systems

$

22,842

 

 

60.4

 

%

 

$

29,733

 

 

64.4

 

%

 

$

29,121

 

 

62.0

 

%

Imaging systems

$

619

 

 

1.6

 

%

 

 

1,694

 

 

3.7

 

%

 

 

3,685

 

 

7.9

 

%

Consumables and other

$

7,164

 

 

19.0

 

%

 

 

8,287

 

 

18.0

 

%

 

 

7,332

 

 

15.6

 

%

Services

$

7,162

 

 

19.0

 

%

 

 

6,429

 

 

13.9

 

%

 

 

6,660

 

 

14.2

 

%

License fees and royalties

$

12

 

 

 

%

 

 

12

 

 

 

%

 

 

128

 

 

0.3

 

%

Total revenue

$

37,799

 

 

100.0

 

%

 

$

46,155

 

 

100.0

 

%

 

$

46,926

 

 

100.0

 

%

 

The Company maintains its cash and cash equivalent accounts with established commercial banks. Such cash deposits periodically exceed the Federal Deposit Insurance Corporation insured limit.

No individual customer represented more than 10% of the Company’s accounts receivable at December 31, 2019. One individual customer represented approximately 12% of the Company’s accounts receivable at December 31, 2018.  

The Company currently purchases certain key components of its products from single suppliers. Although there are a limited number of manufacturers of these key components, management believes that other suppliers could provide similar key components on comparable terms. A change in suppliers, however, could cause delays in manufacturing and a possible loss of sales, which could adversely affect the Company’s business, results of operations and financial condition.